Most Popular

M & A Deals | M & A League Table | Real Assets | Sector Events |  Private Capital Conference

Belgium: UCB expanding capabilities in next‑generation biologics with acquisition of Candid Therapeutics

M&A Nick Herbert -
Euronext-listed UCB, a Belgium-based global biopharmaceutical company focused on severe neurological and immunological conditions, is to acquire Candid Therapeutics, a US-based privately held clinical-stage biotechnology company redefining the treatment of autoimmune and inflammatory diseases through novel T-cell engagers (TCEs) for a total transaction value of up to US$2.2bn - consisting...

Iceland: NIB finances nursing home and healthcare facilities in Reykjavik 

Care Homes Nick Herbert -
NIB, the international financial institution of Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Norway, and Sweden, has signed an ISK4.4bn (US$36m) 10-year indexed loan with the listed Icelandic real estate company Reitir hf. The loan will co-finance the conversion of two former office buildings into a nursing home and health care facilities in Reykjavik at a total project cost of ISK8.75bn. “Reitir is expanding its operations and strengthening its role as a developer with a clear focus on building socially useful infrastructure,” said Guðni Aðalsteinsson, CEO of Reitir. “The two projects demonstrate how existing buildings can be effectively repurposed to meet demographic-driven demand for...